跳至主要内容
临床试验/PACTR202401734091130
PACTR202401734091130尚未招募2 期

Effect of natural cocoa powder consumption on blood lipids, inflammatory and metabolic biomarkers in sickle cell patients at the Ghana Institute of Clinical Genetics (GICG), Korle Bu Teaching Hospital

未提供0 个研究点目标入组 150 人开始时间: 2024年1月2日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Participants who are willing to be followed for the 12-week trial period will be included in the study.
  • Sickle cell patients who are not on any lipid lowering drugs will be included in the RCT.

排除标准

  • Participants on lipid lowering medication prior to phase II will be excluded.
  • Further, participants with complications (liver/renal conditions) will be excluded due to the high potassium content of cocoa

研究者

发起方
未提供

相似试验